Related Experiment Videos

Tumour-suppressor genes in prostatic oncogenesis: a positional approach

R Bookstein1, G S Bova, D MacGrogan

  • 1Canji Inc., San Diego, CA 92121, USA.

Insights

Researchers investigated genetic alterations in prostate cancer, identifying a novel gene, N33, on chromosome 8p22. This gene is silenced by methylation in colorectal cancers, suggesting its potential role in oncogenesis.

Area of Science:

  • Oncology
  • Human Genetics
  • Molecular Biology

Background:

  • Prostate cancer development involves genetic alterations like mutation, methylation, and aneuploidy.
  • Genetic events in prostate oncogenesis, especially in early stages, remain poorly understood.
  • Frequent allelic losses on chromosome 8p suggest novel tumor suppressor loci in prostate cancer.

Purpose of the Study:

  • To identify novel genetic targets in prostate cancer using a positional approach.
  • To investigate allelic loss mapping of chromosome 8p and physical mapping of 8p22.
  • To characterize genes within a frequently deleted region on chromosome 8p22.

Main Methods:

  • Positional cloning and allelic-loss mapping of chromosome 8p.
  • Physical mapping of chromosome band 8p22.
  • Detailed examination of expressed sequences within a 730-970 kb homozygous deletion.
  • Analysis of gene silencing mechanisms, including methylation.

Main Results:

  • A homozygous somatic deletion on chromosome 8p22 was identified in a prostate cancer metastasis.
  • A novel gene, N33, was discovered within this deleted region.
  • N33 was found to be silenced by methylation in colon cancer cell lines and primary colorectal tumors.

Conclusions:

  • Novel genetic alterations, including deletions and gene silencing, are implicated in prostate cancer.
  • The N33 gene, silenced by methylation, is a potential target for further investigation in both prostate and colorectal cancers.
  • Continued characterization of chromosome 8p22 candidates is crucial for understanding prostate cancer genetics.

Related Concept Videos